Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Financial News

Vicarius raises $21.8M in series A

August 18, 2017 4:27 PM UTC

Commercialization company Vicarius Pharma AG (Kuessnacht, Switzerland) raised $21.8 million in a series A round on Aug. 14. CEO of Patheon N.V. (NYSE:PTHN) James Mullen was an investor in the round, and is chairman of Vicarius' board.

The newco partners with U.S. biopharmas to commercialize their first products in the EU. Vicarius offers its partners regulatory, pricing and commercialization strategy advice. It also is responsible for obtaining European marketing authorization for partnered assets, and for related legal and operational obligations...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Patheon N.V.

Vicarius Pharma AG